Unleashing Innovation: The Case for Permissionless R&D in Pharma

   March 22, 2024    Comments Off on Unleashing Innovation: The Case for Permissionless R&D in Pharma    Posted in: Insights

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior…
Source

Continue reading

New patent for Gilead Sciences drug BIKTARVY

   March 22, 2024    Comments Off on New patent for Gilead Sciences drug BIKTARVY    Posted in: Patent Added

Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are twelve…
Source

Continue reading
Biotechblog